Wedgewood Pharmacy, a portfolio company of New Harbor Capital, has agreed to be sold to Partners Group
Highlights Lincoln International's leading advisory position in the animal health sector
News provided by
Share this article
Share this article
CHICAGO, Dec. 10, 2020 /PRNewswire/ -- Lincoln International, a global investment banking advisory firm, is pleased to announce the signing of a definitive agreement whereby New Harbor Capital will sell Wedgewood Pharmacy to Partners Group.
Lincoln International is pleased to announce the signing of a definitive agreement whereby New Harbor Capital will sell Wedgewood Pharmacy to Partners Group
Founded in 1980, Wedgewood is one of the largest providers of compounded animal medications for acute and chronic conditions in the United States and employs more than 700 people in New Jersey, California, Colorado and Arizona. Compounded medications are created and prepared by specialist pharmacists and pharmacy technicians when there is no commercially available alternative. The company holds over 66,000 relationships with veterinarians and directly serves more than 360,000 pet owners annually. Wedgewood has a broad and diverse portfolio of offerings leading to low customer and stock concentration, holds strategic partnerships with veterinary corporate groups and offers a defined value proposition to veterinary clinics and pet owners.